HOME >> MEDICINE >> NEWS
Landmark study results published in NEJM highlight breakthrough treatment for heart failure

MINNEAPOLIS, June 12, 2002 - Hundreds of thousands of Europeans who live with restricted energy, mobility and independence due to heart failure could benefit significantly from a breakthrough treatment featured in tomorrow's New England Journal of Medicine1. The published study results demonstrate the benefit of cardiac resynchronisation (CR) therapy with the InSync system from Medtronic, Inc. (NYSE: MDT) to help many people live well with moderate-to-severe heart failure. Over 3 million people in the G5 European markets alone (UK, Germany, Italy, France & Spain) suffer from heart failure2, a progressive and debilitating condition that is responsible for more hospitalisations than all forms of cancer combined.

Data from the Multicenter InSync Randomised Clinical Evaluation, known as MIRACLE, show that cardiac resynchronisation therapy systems helped many patients improve by at least one functional class, resulted in a greater improvement in patient quality of life than for those receiving drug therapy alone and reduced the risk of hospitalisation from worsening heart failure.

Approximately 450,0003 people in the G5 European countries are candidates for cardiac resynchronisation therapy; these patients have moderate-to-severe heart failure and also suffer from ventricular dysynchrony, which occurs when there is a time delay between the beating of the heart's two lower chambers, or ventricles. Cardiac resynchronisation therapy delivers electrical impulses to both sides of the heart to co-ordinate the contractions of the heart's ventricles and improve its efficiency to increase blood flow to the body.

The MIRACLE study was designed to measure therapeutic benefits of the InSync system, as determined by changes in New York Heart Association (NYHA) functional classification, distance walked in six minutes and improvements in quality of life. Findings are based on data from 453 patients with moderate-to-severe heart failure.

Conducted a
'"/>

Contact: Amanda Boswell
amanda.boswell@ketchum.com
44-207-611-3571
Ketchum
12-Jun-2002


Page: 1 2 3 4

Related medicine news :

1. Landmark survey reveals asthma in children remains significantly out of control in the United States
2. Landmark antidepressant analysis demonstrated significant efficacy of Effexor®/Effexor XR
3. Landmark study shows coenzyme Q10 slows progressive decline in Parkinsons disease
4. Landmark XENDOS study shows Xenical prevents or delays the development of type 2 diabetes
5. Landmark study demonstrates potential for nerve regeneration treatment of stroke
6. Landmark study uncovers reasons behind recurring back injury
7. Landmark clinical trial at 22 medical centers finds implanted heart pumps lengthen and improve lives of terminally ill heart failure patients
8. Landmark dialysis study findings could greatly simplify treatment of kidney disease with peritoneal dialysis
9. Landmark school-based social influences smoking-prevention program found not to work
10. U.S., British scientific societies honor penicillin as International Chemical Landmark
11. CODE-2*: Landmark study on the costs of type 2 diabetes in Europe

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/8/2019)... ... October 08, 2019 , ... PotentiaMetrics, an ... Jerry Henderson as Chief Medical Officer. Dr. Henderson will be responsible for the ... Dr. Henderson previously served as Chair of both the Informatics Governance and the ...
(Date:10/8/2019)... MARINA DEL REY, Calif. (PRWEB) , ... October ... ... Quality Confab for laboratory managers, administrators and pathologists, 4medica® President ... Perfect Payment™ is the first-to-market solution reinventing labs orders management-by starting with ...
(Date:10/8/2019)... ... October 08, 2019 , ... Smile Brands Inc. has been named one ... Comparably. Smile Brands, a leading dental support organization with nearly 440 affiliated practices across ... Smiles for Everyone®. The Happiness Award is the latest in a series of ...
(Date:10/8/2019)... ... 2019 , ... EBSCO Information Services ( EBSCO ) has ... from Dynamic Health™ into the MCN platform. Dynamic Health is EBSCO's ... MCN provides custom policy content, document management software and compliance expertise to healthcare ...
(Date:10/8/2019)... (PRWEB) , ... October 08, 2019 , ... On November 9, 2019, husband and wife ... No Cost Dental Day . 2019 marks the ninth consecutive year that Mansouri ... community who are in need. , This event has always had a great turnout, serving ...
Breaking Medicine News(10 mins):
(Date:10/15/2019)... FORESIDE, Maine (PRWEB) , ... ... ... Standards1 releases VALIDATE® LP2 linearity and calibration verification kit, for Roche cobas® ... A (Apo-A1) and Apolipoprotein B (Apo-B). Each VALIDATE® LP2 kit, liquid, ...
(Date:10/11/2019)... ... October 11, 2019 , ... Five New York fitness studios have teamed up to create ... opportunity to tour and sample a variety of the top group exercise classes offered on ... produced by Club Pilates on W. 57th St., the Hell’s Kitchen Sweat Crawl will feature ...
(Date:10/10/2019)... ... October 10, 2019 , ... Ovation Fertility is once ... of reproductive medicine, with six abstracts accepted for poster presentations at the ASRM ... October 12-16, 2019, in Philadelphia. , “Ovation will have a prominent presence in ...
Breaking Medicine Technology:
Cached News: